Literature DB >> 33000429

Metabolic landscape of oral squamous cell carcinoma.

Jéssica Gardone Vitório1, Filipe Fideles Duarte-Andrade1, Thaís Dos Santos Fontes Pereira1, Felipe Paiva Fonseca1, Larissa Stefhanne Damasceno Amorim1, Roberta Rayra Martins-Chaves1, Carolina Cavaliéri Gomes2, Gisele André Baptista Canuto3, Ricardo Santiago Gomez4.   

Abstract

BACKGROUND: Head and neck cancers are the seventh most common type of cancer worldwide, with almost half of the cases affecting the oral cavity. Oral squamous cell carcinoma (OSCC) is the most common form of oral cancer, showing poor prognosis and high mortality. OSCC molecular pathogenesis is complex, resulting from a wide range of events that involve the interplay between genetic mutations and altered levels of transcripts, proteins, and metabolites. Metabolomics is a recently developed sub-area of omics sciences focused on the comprehensive analysis of small molecules involved in several biological pathways by high throughput technologies. AIM OF REVIEW: This review summarizes and evaluates studies focused on the metabolomics analysis of OSCC and oral premalignant disorders to better interpret the complex process of oral carcinogenesis. Additionally, the metabolic biomarkers signatures identified so far are also included. Moreover, we discuss the limitations of these studies and make suggestions for future investigations. KEY SCIENTIFIC CONCEPTS: Although many questions about the metabolic features of OSCC have already been answered in metabolomic studies, further validation and optimization are still required to translate these findings into clinical applications.

Entities:  

Keywords:  Biomarkers; Mass spectrometry; Metabolites; Metabolomics; Oral cancer; Oral potentially malignant disorders; Oral squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 33000429     DOI: 10.1007/s11306-020-01727-6

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  10 in total

1.  Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation.

Authors:  Chen-Xing Hou; Guang-Yan Mao; Qiu-Wangyue Sun; Ying Meng; Qing-Hai Zhu; Yu-Ting Tang; Wei Han; Nan-Nan Sun; Xiao-Meng Song; Chen-Xing Wang; Jin-Hai Ye
Journal:  Ann Surg Oncol       Date:  2022-07-12       Impact factor: 4.339

Review 2.  Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Authors:  Jong Chul Park; Hari N Krishnakumar; Srinivas Vinod Saladi
Journal:  Curr Oncol       Date:  2022-06-08       Impact factor: 3.109

3.  Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma.

Authors:  Liangyin Wu; Jun Liu; Wenli Li
Journal:  J Dent Sci       Date:  2021-11-27       Impact factor: 3.719

4.  Preparation of Novel ICT-CMC-CD59sp Drug-Loaded Microspheres and Targeting Anti-Tumor Effect on Oral Squamous Cell Carcinoma.

Authors:  Xiang Gao; Wanchun Wang; Meihua Gao
Journal:  Front Bioeng Biotechnol       Date:  2022-03-21

Review 5.  Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions.

Authors:  Giuseppe Gattuso; Salvatore Crimi; Alessandro Lavoro; Roberta Rizzo; Giorgia Musumarra; Simona Gallo; Flavia Facciponte; Sabrina Paratore; Angela Russo; Roberto Bordonaro; Gaetano Isola; Alberto Bianchi; Massimo Libra; Luca Falzone
Journal:  Noncoding RNA       Date:  2022-08-10

6.  Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells.

Authors:  Gunng-Shinng Chen; Ssu-Yu Chen; Shu-Ting Liu; Cheng-Chih Hsieh; Shiao-Pieng Lee; Shih-Ming Huang
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

7.  COL11A1 as a potential prognostic target for oral squamous cell carcinoma.

Authors:  Yong-Bin Di; Yang Bao; Jie Guo; Wei Liu; Su-Xin Zhang; Guan-Hua Zhang; Tian-Ke Li
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

8.  Corneodesmosin as a potential target of oral squamous cell carcinoma.

Authors:  Yong-Bin Di; Yang Bao; Jie Guo; Wei Liu; Su-Xin Zhang; Guan-Hua Zhang; Tian-Ke Li
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

9.  PKM2 Modulation in Head and Neck Squamous Cell Carcinoma.

Authors:  Verena Boschert; Jonas Teusch; Urs D A Müller-Richter; Roman C Brands; Stefan Hartmann
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

Review 10.  Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma.

Authors:  Yuhan Wang; Xiaoxin Zhang; Shuai Wang; Zihui Li; Xinyang Hu; Xihu Yang; Yuxian Song; Yue Jing; Qingang Hu; Yanhong Ni
Journal:  Biomolecules       Date:  2022-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.